English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 2 August 2023, 21:38 HKT/SGT
Share:
Kingworld Medicines Expects 1H Profit Increased By 35%-40%
Demonstrating Strong Business Performance and Competitive Strengths

HONG KONG, Aug 2, 2023 - (ACN Newswire) - Kingworld Medicines Group ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced a projected rise in profit for the first half of the fiscal year. Based on a preliminary assessment of the unaudited consolidated management accounts of the Group for the six months ending June 30, 2023, the Group anticipates a profit surge ranging from approximately 35% to 40% for the period, compared to the same period last year.

The Board attributes this profit increase to increased revenue and gross profit stemming from the distribution of imported branded pharmaceutical and healthcare products in China, with growth rates reaching approximately 30% to 35% and 15% to 20%, respectively. Additionally, the Group's share of profit from a joint venture saw a boost of approximately 55% to 60% compared to the same period last year. This surge is attributed to the market recovery after the COVID-19 pandemic control measures.

Kingworld Medicines is a company specializing in the distribution of imported branded pharmaceutical and healthcare products in China. The Group adeptly navigated post-pandemic market changes, propelling business expansion by leveraging its industry strengths.

Mr. Zhao Lisheng, Chairman of the Board of Kingworld Medicines Group, commented: "The Group's profit increase was mainly due to market recovery and the Group's employees' unremitting efforts, which adapted post-pandemic. The Group's strengths lie in its strong capabilities in distributing pharmaceutical and healthcare products and its acute insights into the market. Besides, the Group has achieved long-term steady growth by continuously improving efficiency and expanding its business."

Looking ahead, Kingworld Medicines Group will continue to focus on increasing market share, expanding business coverage, and improving efficiency to further enhance the company's profitability and market competitiveness.


Topic: Press release summary Sectors: Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025  
Feb 3, 2025 22:30 HKT/SGT
Formerra Expands Leadership Team to Support Accelerated Global Growth  
Feb 3, 2025 22:15 HKT/SGT
Eisai to Provide Guidance on Reducing the Risk of Cognitive Decline and Nutrition, and Development Guidelines for Home Delivery Meals/Meal Kits to Food-Related Companies  
Monday, February 3, 2025 4:23:00 PM
MHI Group Presents "Best Innovation 2024" Awards for Products and Activities that Contribute to Solving Social Issues  
Monday, February 3, 2025 1:31:00 PM
Fujitsu and Tokai National Higher Education and Research System leverage explainable AI to enhance space weather prediction in collaboration with JAXA  
Monday, February 3, 2025 11:05:00 AM
Enjoy Anime Tokyo Station in the Metaverse! ANIME TOKYO STATION ON ROBLOX Opens at 3:00 p.m. on January 31, 2025!  
Saturday, February 1, 2025 7:00:00 AM
DENSO Announces Third Quarter Financial Results  
Friday, January 31, 2025 5:09:00 PM
Rally Driver Hiroshi Masuoka Receives the Person of Sports Merit Award in Japan  
Friday, January 31, 2025 2:12:00 PM
TANAKA PRECIOUS METAL TECHNOLOGIES Launches Visi Fine(R): A Group of Precious Metal Materials for Medical Device Components  
Friday, January 31, 2025 10:00:00 AM
The USPA and U.S. Polo Assn. Celebrate 135th Anniversary with Global Sport and Fashion Events and Launch of "Born to Play"  
Jan 30, 2025 20:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575